Nanobiotix S.A. (NBTX) stock
NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
$27.45−1.09 (-3.82%)
Close on Nov 17, 2026Market cap $1.33BP/E –Yield –
Nanobiotix enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Nanobiotix's enterprise value was $1.58T on Nov 11, 2026, against $977.88B a year earlier. Over the last 5 years it ranged from $74.54B to $1.94T, with a median of $215.58B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.58T | +44.2% |
| 2025 | Dec 31, 2025 | $1.09T | +931.7% |
| 2024 | Dec 31, 2024 | $105.92B | -58.3% |
| 2023 | Dec 29, 2023 | $253.70B | +99.1% |
| 2022 | Dec 30, 2022 | $127.40B | -35.5% |
| 2021 | Dec 31, 2021 | $197.41B | -44.7% |
| 2020 | Dec 31, 2020 | $356.88B | – |
See a number that looks wrong?